Based on the glycolytic status of the cancer cells and tumor stroma (characterized by the expression levels of glucose transporter-1 protein (GLUT-1) and carbonic anhydrase IX (CAIX)), Choi et al. classified 740 samples of breast tumors into four metabolic phenotypes [46]. This evidence concerns the gene SLC2A1 and cancer.